CUMBERLAND PHARMACEUTICALS INC 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Jun 2, 2017
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Purchase
Common Stock
2017-05-31$6.95/sh+300$2,085→ 14,947 total
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Jun 2, 2017
Common Stock